State of Wisconsin Investment Board’s Avadel Pharmaceuticals AVDL Stock Holding History

State of Wisconsin Investment Board’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-107,104	Closed	-$2.31M	–	2502
2025 Q4	$2.31M	Sell	107,104 -58,608	-35%	-$1.14M	0.01%	1359
2025 Q3	$2.53M	Sell	165,712 -57,326	-26%	-$746K	0.01%	1272
2025 Q2	$1.97M	Sell	223,038 -2,130	-0.9%	-$18.7K	﹤0.01%	1304
2025 Q1	$1.76M	Buy	225,168 +111,302	+98%	+$932K	﹤0.01%	1289
2024 Q4	$1.2M	Buy	113,866 +60,615	+114%	+$736K	﹤0.01%	1457
2024 Q3	$698K	Buy	+53,251	New	+$811K	﹤0.01%	1711

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

State of Wisconsin Investment Board's AVDL Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 107,104 shares — an estimated $2.31M sold.

State of Wisconsin Investment Board first reported a position in AVDL in Q3 2024 and held it in 6 quarters. The position peaked at $2.53M in Q3 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

State of Wisconsin Investment Board reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
State of Wisconsin Investment Board sold 107,104 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.31M.
State of Wisconsin Investment Board first reported a position in Avadel Pharmaceuticals in Q3 2024 and held it in 6 quarters.
State of Wisconsin Investment Board's Avadel Pharmaceuticals position peaked at $2.53M in Q3 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.